SO
TEVA icon

STRS Ohio’s Teva Pharmaceuticals TEVA Stock Holding History

STRS Ohio’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86M Sell
291,072
-246,778
-46% -$8.22M 0.04% 382
2026
Q1 		$16.2M Sell
537,850
-28,711
-5% -$924K 0.06% 305
2025
Q4 		$17.7M Sell
566,561
-196,346
-26% -$4.84M 0.07% 296
2025
Q3 		$15.4M Sell
762,907
-26,238
-3% -$461K 0.06% 327
2025
Q2 		$13.2M Buy
789,145
+636,015
+415% +$10.3M 0.05% 349
2025
Q1 		$2.35M Sell
153,130
-472,000
-76% -$8.43M 0.01% 563
2024
Q4 		$13.8M Sell
625,130
-584
-0.1% -$10.6K 0.05% 328
2024
Q3 		$11.3M Sell
625,714
-100,000
-14% -$1.75M 0.04% 362
2024
Q2 		$11.8M Sell
725,714
-64,880
-8% -$999K 0.05% 348
2024
Q1 		$11.2M Buy
790,594
+171,700
+28% +$2.16M 0.04% 352
2023
Q4 		$6.46M Buy
618,894
+956
+0.2% +$8.93K 0.03% 423
2023
Q3 		$6.3M Buy
617,938
+282,300
+84% +$2.63M 0.03% 416
2023
Q2 		$2.53M Buy
335,638
+142
+0% +$1.15K 0.01% 550
2023
Q1 		$2.97M Sell
335,496
-851,810
-72% -$8.42M 0.01% 524
2022
Q4 		$10.8M Buy
1,187,306
+561,595
+90% +$4.9M 0.05% 373
2022
Q3 		$5.05M Buy
625,711
+133,811
+27% +$1.18M 0.02% 455
2022
Q2 		$3.7M Hold
491,900
– – 0.02% 507
2022
Q1 		$4.62M Hold
491,900
– – 0.02% 509
2021
Q4 		$3.94M Buy
491,900
+410,900
+507% +$3.71M 0.01% 537
2021
Q3 		$788K Hold
81,000
– – ﹤0.01% 1268
2021
Q2 		$801K Sell
81,000
-1,200
-1% -$12.7K ﹤0.01% 1334
2021
Q1 		$948K Sell
82,200
-90,900
-53% -$1.04M ﹤0.01% 1201
2020
Q4 		$1.67M Hold
173,100
– – 0.01% 780
2020
Q3 		$1.56M Sell
173,100
-633,946
-79% -$6.71M 0.01% 720
2020
Q2 		$9.95M Sell
807,046
-97,000
-11% -$1.1M 0.04% 343
2020
Q1 		$8.12M Sell
904,046
-573,854
-39% -$5.88M 0.04% 349
2019
Q4 		$14.5M Hold
1,477,900
– – 0.06% 322
2019
Q3 		$10.2M Sell
1,477,900
-173,800
-11% -$1.33M 0.04% 361
2019
Q2 		$15.2M Buy
1,651,700
+1,569,500
+1,909% +$18.9M 0.07% 307
2019
Q1 		$1.29M Sell
82,200
-1,036,943
-93% -$18.3M 0.01% 738
2018
Q4 		$17.3M Sell
1,119,143
-140,800
-11% -$2.89M 0.09% 273
2018
Q3 		$27.1M Buy
1,259,943
+402,800
+47% +$9.35M 0.12% 222
2018
Q2 		$20.8M Buy
857,143
+372,150
+77% +$7.59M 0.09% 272
2018
Q1 		$8.29M Buy
484,993
+159,300
+49% +$3.11M 0.04% 381
2017
Q4 		$6.17M Buy
325,693
+269,700
+482% +$4.06M 0.03% 437
2017
Q3 		$985K Hold
55,993
– – ﹤0.01% 866
2017
Q2 		$1.86M Hold
55,993
– – 0.01% 636
2017
Q1 		$1.8M Hold
55,993
– – 0.01% 656
2016
Q4 		$2.03M Sell
55,993
-50,000
-47% -$2M 0.01% 632
2016
Q3 		$4.88M Sell
105,993
-524,600
-83% -$27.4M 0.02% 500
2016
Q2 		$31.7M Buy
630,593
+21,091
+3% +$1.12M 0.14% 195
2016
Q1 		$32.6M Hold
609,502
– – 0.15% 192
2015
Q4 		$40M Hold
609,502
– – 0.18% 155
2015
Q3 		$34.4M Sell
609,502
-377,000
-38% -$24.4M 0.16% 173
2015
Q2 		$58.3M Sell
986,502
-128,000
-11% -$7.9M 0.26% 107
2015
Q1 		$69.4M Buy
1,114,502
+236,652
+27% +$13.8M 0.31% 84
2014
Q4 		$50.5M Hold
877,850
– – 0.22% 133
2014
Q3 		$47.2M Hold
877,850
– – 0.21% 132
2014
Q2 		$46M Sell
877,850
-225,000
-20% -$11.5M 0.21% 136
2014
Q1 		$58.3M Sell
1,102,850
-29,896
-3% -$1.38M 0.26% 116
2013
Q4 		$45.4M Sell
1,132,746
-121,490
-10% -$4.78M 0.2% 145
2013
Q3 		$47.4M Buy
1,254,236
+25,000
+2% +$975K 0.21% 143
2013
Q2 		$48.2M Buy
+1,229,236
New +$47.9M 0.21% 139

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

STRS Ohio's TEVA Position: Q2 2026 in Review

STRS Ohio reduced its Teva Pharmaceuticals (TEVA) stake by 46% in Q2 2026, selling an estimated $8.22M and leaving 291,072 shares worth $9.86M. The position accounts for 0.04% of the portfolio, ranked #382.

STRS Ohio first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $69.4M in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • STRS Ohio held 291,072 shares of Teva Pharmaceuticals worth $9.86M as of Q2 2026.
  • STRS Ohio sold 246,778 Teva Pharmaceuticals shares in Q2 2026, an estimated $8.22M.
  • Teva Pharmaceuticals made up 0.04% of STRS Ohio's portfolio in Q2 2026, its #382 holding.
  • STRS Ohio first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • STRS Ohio's Teva Pharmaceuticals position peaked at $69.4M in Q1 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.